The Ontario Bioscience Innovation Organization (OBIO®) – Capital Access Advisory Program (CAAP®) is currently open and accepting applications until September 16, 2022.
The Disruptive Technology Solutions for Cell and Gene Therapy Challenge Program supports the research and development of affordable and accessible therapy solutions for Canadians living with chronic and rare diseases and conditions.